University of Wisconsin-Madison
Madison, Wisconsin, 53792-9988, United States
NCT Number: NCT00593918
In this project we will study the capacity for single nucleotide polymorphisms (SNP) in TLR4 gene to induce varying levels of inflammatory chemokine and cytokine production.
Looking for future studies?
Notify MeUp to 24 month
All sexes
Observational
Madison, Wisconsin, 53792-9988, United States
Infection with RSV is the most common cause of respiratory tract illnesses (LRIs) in the first 3 years of life. There are significant social and health care costs associated with RSV-LRIs. More than 3% of US children are hospitalized each year due to RSV and 500 die annually. Several longitudinal studies have also suggested that children who have RSV-LRIs are at substantially increased risk of developing asthma in the first 3 years after infection and bronchial hyperresponsiveness (BHR) many years after the primary infection. Mechanisms involved in RSV disease are not well understood. Recent reports suggest that RSV may initiate the innate immune response through the pattern recognition receptor, Toll like receptor-4 (TLR4). In this project we will study the capacity for single nucleotide polymorphisms (SNP) in TLR4 gene to induce varying levels of inflammatory chemokine and cytokine production. It has been suggested that such a mechanism may result in altered immune responses to RSV infection and different clinical outcomes. This research has direct application to improving our understanding of bronchiolitis in early childhood, particularly those factors that influence severity of the disease, and may have implications for possible therapy of patients with bronchiolitis in the future.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1-5 days during acute illness (not after day 5 of illness)
Interferon a2 was measured from nasal lavage samples by Luminex multiplex assay.
Time frame: 1-5 days during acute illness (not after day 5 of illness)
IL-2 measured from nasal lavage samples by Luminex multiplex assay
University of Wisconsin, Madison
Other
Innate Immunity and RSV Infection in Children
Acronym: IIRI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06551506
Infections, Mononegavirales Infections
Atlanta, Georgia, United States
View Trial DetailsNCT06604767
Infections, Metapneumovirus Infection
Blacktown, New South Wales, Australia
View Trial DetailsNCT06134648
Healthy Volunteers, Human Metapneumovirus
Los Alamitos, California, United States
View Trial DetailsNCT06251024
Healthy Volunteers, Infections
Botany, New South Wales, Australia
View Trial Details